1887

Abstract

Colorectal cancer (CRC) is one of the most common cancers and poses heavy burden on global health. The relationship between mucosal microbiome composition and colorectal gene expression are rarely studied. In this study, we integrated transcriptome data with microbiome data to investigate the relationship between them in colorectal cancer patients.

. Previous studies have identified the contribution of gut microbiota and DEGs to the pathogenesis of CRC, but the relationship between mucosal microbiome composition and colorectal gene expression are rarely studied.

In this study, we integrated transcriptome data with microbiome data to investigate the relationship between mucosal microbiome composition and colorectal gene expression.

First, three independent CRC gene expression profiles (GSE184093, GSE156355 and GSE146587) from Gene Expression Omnibus (GEO) were used to identify differentially expressed genes (DEGs). Second, another dataset (GSE163366) was used to analyse gut mucosal microbiome differential abundance. GO (Gene Ontology) function and KEGG (Kyoto Encyclopaedia of Genes and Genomes) pathway enrichment analyses of the DEGs were performed. Protein-protein interactions (PPIs) of the DEGs were constructed. The Spearman correlation analysis was computed between host DEGs and gut microbiome abundance data.

A total of 1036 upregulated DEGs and 1194 downregulated DEGs between noncancerous tissues and cancerous tissues were identified based on the analysis. One significant module with a score 37.65 was selected out via MCODE including 41 upregulated DEGs, which are were mostly enriched in two pathways, including microtubule binding and tubulin binding. In particular, significant negative correlations are prevalent between and the 41 DEGs with the correlation ranging between −0.54 and −0.35, and there commonly exist significant positive correlations between and the 41 DEGs with the correlation ranging between 0.42 and 0.54, indicating that and are two of the most important microbes interacting with the gene regulation.

Our results demonstrate significant correlation between some gut microbes and DEGs, providing a comprehensive bioinformatics analysis of them for future investigation into the molecular mechanisms and biomarkers.

Funding
This study was supported by the:
  • Military medical innovation project (Award 18CXZ025)
    • Principle Award Recipient: XiaohuiDu
  • National Natural Science Foundation of China (Award 81871317)
    • Principle Award Recipient: XiaohuiDu
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001596
2022-09-22
2024-04-29
Loading full text...

Full text loading...

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394–424 [View Article]
    [Google Scholar]
  2. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67:177–193 [View Article]
    [Google Scholar]
  3. Ding X, Duan H, Luo H. Identification of core gene expression signature and key pathways in colorectal ancer. Front Genet 2020; 11:45 [View Article]
    [Google Scholar]
  4. Liang B, Li C, Zhao J. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Med Oncol 2016; 33:111 [View Article]
    [Google Scholar]
  5. Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008; 5:588–599 [View Article]
    [Google Scholar]
  6. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S et al. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 2009; 35:201–209 [View Article]
    [Google Scholar]
  7. Bustin SA, Dorudi S. Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev Mol Diagn 2004; 4:599–607 [View Article]
    [Google Scholar]
  8. Lascorz J, Hemminki K, Försti A. Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development. J Carcinog 2011; 10:7 [View Article]
    [Google Scholar]
  9. Ma C-T, Luo H-S, Gao F, Tang Q-C, Chen W. Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. Oncol Lett 2018; 16:2606–2612 [View Article]
    [Google Scholar]
  10. Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol 2016; 7:e200 [View Article]
    [Google Scholar]
  11. Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 2014; 63:761–770 [View Article]
    [Google Scholar]
  12. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014; 12:661–672 [View Article]
    [Google Scholar]
  13. Saracut C, Molnar C, Russu C, Todoran N, Vlase L et al. Secondary bile acids effects in colon pathology. Experimental mice study 2015624 [View Article]
    [Google Scholar]
  14. Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc 2012; 87:701–730 [View Article]
    [Google Scholar]
  15. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M et al. Fusobacterium nucleatum and T Cells in colorectal carcinoma. JAMA Oncol 2015; 1:653–661 [View Article]
    [Google Scholar]
  16. Chen GY, Shaw MH, Redondo G, Núñez G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res 2008; 68:10060–10067 [View Article]
    [Google Scholar]
  17. Bellaguarda E, Chang EB. IBD and the gut microbiota--from bench to personalized medicine. Curr Gastroenterol Rep 2015; 17:15 [View Article]
    [Google Scholar]
  18. Contaldo M, Fusco A, Stiuso P, Lama S, Gravina AG et al. Oral microbiota and salivary levels of oral pathogens in gastro-intestinal diseases: current knowledge and exploratory study. Microorganisms 2021; 9:1064 [View Article]
    [Google Scholar]
  19. Contaldo M, Lucchese A, Lajolo C, Rupe C, Di Stasio D et al. The oral microbiota changes in orthodontic patients and effects on oral health: an overview. J Clin Med 2021; 10:780 [View Article]
    [Google Scholar]
  20. Lin C, Cai X, Zhang J, Wang W, Sheng Q et al. Role of Gut microbiota in the development and treatment of colorectal cancer. Digestion 2019; 100:72–78 [View Article]
    [Google Scholar]
  21. Zhang Q, Zhao H, Wu D, Cao D, Ma W. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer. BMC Microbiol 2020; 20:308 [View Article]
    [Google Scholar]
  22. Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 2006; 7:252 [View Article]
    [Google Scholar]
  23. Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012; 16:284–287 [View Article]
    [Google Scholar]
  24. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43:D447–52 [View Article]
    [Google Scholar]
  25. Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks; 2003; 2
  26. Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol 2012; 8:e1002687 [View Article]
    [Google Scholar]
  27. Matsumoto Y, Saito M, Saito K, Kanke Y, Watanabe Y et al. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis. Oncol Lett 2018; 15:2188–2194 [View Article]
    [Google Scholar]
  28. Wandke C, Barisic M, Sigl R, Rauch V, Wolf F et al. Human chromokinesins promote chromosome congression and spindle microtubule dynamics during mitosis. J Cell Biol 2012; 198:847–863 [View Article]
    [Google Scholar]
  29. Sung W-W, Lin Y-M, Wu P-R, Yen H-H, Lai H-W et al. High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients. BMC Cancer 2014; 14:951 [View Article]
    [Google Scholar]
  30. Huang W-W, Ko S-W, Tsai H-Y, Chung J-G, Chiang J-H et al. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol 2011; 38:1067–1073 [View Article]
    [Google Scholar]
  31. Lee D-W, Han S-W, Kang J-K, Bae JM, Kim H-P et al. Association between Fusobacterium nucleatum, pathway mutation, and patient prognosis in Colorectal Cancer. Ann Surg Oncol 2018; 25:3389–3395 [View Article]
    [Google Scholar]
  32. Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut 2019; 68:1335–1337 [View Article]
    [Google Scholar]
  33. Wong SH, Kwong TNY, Chow T-C, Luk AKC, Dai RZW et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 2017; 66:1441–1448 [View Article]
    [Google Scholar]
  34. Ma C-T, Luo H-S, Gao F, Tang Q-C, Chen W. Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. Oncol Lett 2018; 16:2606–2612 [View Article]
    [Google Scholar]
  35. Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol 2016; 7:e200 [View Article]
    [Google Scholar]
  36. Yuan L, Zhang S, Li H, Yang F, Mushtaq N et al. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer. Biomed Pharmacother 2018; 108:184–193 [View Article]
    [Google Scholar]
  37. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012; 7:e39743 [View Article]
    [Google Scholar]
  38. Richard ML, Liguori G, Lamas B, Brandi G, da Costa G et al. Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes 2018; 9:131–142 [View Article]
    [Google Scholar]
  39. Sarhadi V, Lahti L, Saberi F, Youssef O, Kokkola A et al. Gut microbiota and host gene mutations in colorectal cancer patients and controls of Iranian and Finnish Origin. Anticancer Res 2020; 40:1325–1334 [View Article]
    [Google Scholar]
  40. Bisht V, Nash K, Xu Y, Agarwal P, Bosch S et al. Integration of the microbiome, metabolome and transcriptomics data identified novel metabolic pathway regulation in colorectal cancer. Int J Mol Sci 2021; 22:5763 [View Article]
    [Google Scholar]
  41. Alshareef SH, Alsobaie NA, Aldeheshi SA, Alturki ST, Zevallos JC et al. Association between race and cancer-related mortality among patients with colorectal cancer in the United States: a retrospective cohort tudy. Int J Environ Res Public Health 2019; 16:E240 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001596
Loading
/content/journal/jmm/10.1099/jmm.0.001596
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error